
CYBIN INC. — Investor Relations & Filings
Cybin Inc. is a late-stage clinical neuropsychiatry company dedicated to revolutionizing mental healthcare by developing novel psychedelic-based therapeutics. The company utilizes proprietary drug discovery platforms, innovative drug delivery systems, and a deuterated chemical process to engineer next-generation, patent-protected drug candidates from tryptamine-based scaffolds. Its lead programs include CYB003, a deuterated psilocybin analog for Major Depressive Disorder (MDD) that has received FDA Breakthrough Therapy Designation, and CYB004 for the treatment of Generalized Anxiety Disorder (GAD). Cybin aims to create safer, more effective, and commercially scalable treatments for various mental health conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | |
| 6-K Filing | 2026-02-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38139607 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | ||
| 35894872 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | ||
| 34694400 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34693984 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34648069 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | ||
| 31978132 | 6-K Filing | 2026-02-18 | English | ||
| 31978135 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31978134 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31978131 | 6-K Filing | 2026-02-17 | English | ||
| 31978136 | 6-K Filing | 2026-02-13 | English | ||
| 31978133 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31978137 | 6-K Filing | 2026-02-10 | English | ||
| 13343163 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 13343166 | 6-K | 2026-01-05 | English | ||
| 13343164 | Regulatory Filings 2026 | 2026-01-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
CYBIN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33911/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33911 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33911 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33911 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33911}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CYBIN INC. (id: 33911)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.